Muhammad M Khan

Muhammad M Khan is a seasoned professional in regulatory affairs with extensive experience in the pharmaceutical sector. Currently serving as Senior Director of Regulatory Affairs at Kymera Therapeutics since April 2021, Muhammad previously held the position of Director of Global Regulatory Affairs at Blueprint Medicines from January 2018 to April 2021. Previous roles include regulatory affairs positions at ARIAD Pharmaceuticals, Inc. and a regulatory affairs co-op at Alnylam Pharmaceuticals. Muhammad's early career features experience as a pharmacist at Sanofi and as a manufacturing officer at Martin Dow Limited. Educational qualifications include a Master of Science in Regulatory Affairs for Drug, Biologic, and Medical Devices from Northeastern University and a Doctor of Pharmacy from Karachi University.